Satovsky Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Satovsky Asset Management's BMY Position: Q1 2026 in Review
Satovsky Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 5,315 shares — an estimated $287K sold.
Satovsky Asset Management first reported a position in BMY in Q2 2021 and held it in 19 quarters. The position peaked at $407K in Q1 2023. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Satovsky Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- Satovsky Asset Management sold 5,315 Bristol-Myers Squibb shares in Q1 2026, an estimated $287K.
- Satovsky Asset Management first reported a position in Bristol-Myers Squibb in Q2 2021 and held it in 19 quarters.
- Satovsky Asset Management's Bristol-Myers Squibb position peaked at $407K in Q1 2023.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Satovsky Asset Management's 13F filing for Q1 2026, filed 14 May 2026.